Dark

NITE
The Nightview Fund
stock NYSE ETF

At Close

Jan 30, 2026

36.92USD-0.644%(-0.24)206

0.00Bid 0.00Ask 0.00Spread

Pre-market

0.00USD-100.000%(-37.16)0

After-hours

0.00USD0.000%(0.00)0

Overview HistoricalExchangesShortsTrends

open chart

Market Cap

1.24B

Headquarters

Cincinnati, Ohio, USA

Industry

Biotechnology

OMER XLV

NITE Stats

Avg. Vol. 10 Day

759

Avg. Vol. 30 Day

1,425

Market Cap

1,235,746,763

Shares Out.

33,479,999

On/Off Exchange

49%/51%

6 Month Beta

1.42

1 Year Beta

1.38

2 Year Beta

1.41

52 Week Low

22.38

52 Week High

38.42

SMA50

36.78

SMA200

33.26

1 Week

-2.67%

1 Month

+0.81%

3 Month

+1.81%

6 Month

+15.14%

1 Year

+17.62%

2 Year

+48.37%

5 Year

+45.26%

Profile

Nightstar Therapeutics Ltd is a clinical-stage gene therapy company. It is focused on developing and commercializing a pipeline of novel and potentially curative, one-time retinal gene therapies for patients suffering from rare inherited retinal diseases.

NITE Stock Summary

The Nightview Fund (NYSE:NITE) stock price today is $36.92, and today's volume is 206. NITE is down -0.644% today. The 30 day average volume is 1,425. NITE market cap is 1.24B with 33,479,999 shares outstanding.

document.getElementById("DftZNp").onerror = function(){this.style.display='none';}; .dark-mode .HvmHdP{ color: white; background-color: #333333; border: 2px solid white; }.light-mode .HvmHdP{ color: #333333; background-color: white; border: 2px solid #333333; }NITEThe Nightview Fundstock NYSE ETF

NITE Stock Summary

NITE
The Nightview Fund
stock NYSE ETF